2 Acapella and TheraPEPĪvailable from Smiths Medical, the TheraPEP device is designed to treat CF and other lung diseases with secretory problems, to prevent or reverse atelectasis, and as a therapy for patients recovering from surgery. The therapy is “goal-based” and ends when no more mucus can be expectorated, with therapy lasting approximately 5-15 minutes. According to Aptalis, the therapy is administered in two stages: (1) mucus loosening and mucus mobilization, and (2) mucus elimination. 2įlutter functions by vibrating the airways, intermittently increasing endobronchial pressure, and accelerating expiratory airflow. The Flutter mucus clearance device, manufactured by Aptalis Pharma US Inc, provides PEP therapy for patients with atelectasis, bronchitis, bronchiectasis, cystic fibrosis, COPD, asthma or other conditions producing retained secretions, according to the company.

1 In this article, RT takes a look at some of the latest PEP devices available on the market, including some new oscillating PEP (OPEP) devices. It also holds airways open, keeping them from closing,” according to the Cystic Fibrosis Foundation. The therapy, which is administered by breathing through a special device, “helps air get behind the mucus and helps move it from lung and airway walls.

One of the most frequently prescribed airway clearance therapy (ACT) options for patients with chronic lung conditions is positive expiratory pressure therapy (PEP).

Flutter valve for ocopella